Profile data is unavailable for this security.
About the company
Astena Holdings Co Ltd, formerly Iwaki & Co Ltd is a Japan-based company primarily engaged in the fine chemicals business, medical business, health & beauty care (HBC) and food business, and industrial chemicals business. The Company operates through four business segments. The Fine Chemicals segment is engaged in manufacture and sale of pharmaceutical raw materials and pharmaceuticals. The Medical segment is engaged in the manufacturing and sales of pharmaceutical products. The HBC and Food segment is engaged in the manufacture and sale of cosmetic raw materials, functional food raw materials, general use medicines and related products, as well as cosmetics. The Industrial Chemicals segment manufactures and sells chemicals for electronic industries, surface treatment chemicals, chemical products, surface treatment chemical raw materials, as well as to printed circuit board and other manufacturing plants. The other businesses include consulting services and others.
- Revenue in JPY (TTM)62.74bn
- Net income in JPY2.19bn
- Incorporated1941
- Employees1.42k
- LocationAstena Holdings Co Ltd4-8-2, Nihombashi Hon-choCHUO-KU 103-8403JapanJPN
- Phone+81 332790481
- Fax+81 332713240
- Websitehttps://www.astena-hd.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Symbio Pharmaceuticals Ltd | 1.31bn | -4.78bn | 10.96bn | 108.00 | -- | 8.00 | -- | 8.38 | -95.49 | -95.49 | 26.04 | 21.39 | 0.296 | 1.37 | 3.83 | -- | -108.11 | -19.84 | -140.91 | -24.15 | 72.45 | 74.71 | -365.25 | -26.66 | 2.74 | -44.43 | 0.6092 | -- | -46.69 | -15.23 | -24.59 | -- | -11.15 | -- |
| Wakamoto Pharmaceutical Co Ltd | 9.29bn | 298.60m | 11.18bn | 286.00 | 37.31 | 0.9214 | 15.10 | 1.20 | 8.60 | 8.60 | 267.77 | 348.39 | 0.6006 | 1.62 | 3.06 | 32,493,160.00 | 1.93 | -0.0678 | 2.22 | -0.0781 | 47.70 | 48.65 | 3.21 | -0.1246 | 2.42 | -- | 0.0082 | -- | 0.6595 | -6.53 | -40.86 | -- | 21.87 | -- |
| CellSeed Inc | 83.68m | -1.10bn | 12.98bn | 38.00 | -- | 9.84 | -- | 155.06 | -31.83 | -31.83 | 2.41 | 35.67 | 0.0409 | 0.6561 | 3.81 | -- | -54.00 | -46.88 | -59.08 | -50.95 | 51.09 | 53.64 | -1,319.46 | -593.85 | 5.81 | -- | 0.0949 | -- | -56.71 | -15.95 | -28.41 | -- | 21.04 | -- |
| Stella Pharma Corp | 968.76m | -279.32m | 13.24bn | 43.00 | -- | 4.91 | -- | 13.67 | -8.21 | -8.21 | 28.47 | 79.22 | 0.1966 | 0.0944 | 2.91 | 22,529,260.00 | -5.67 | -16.41 | -5.96 | -18.19 | 87.88 | 87.03 | -28.83 | -176.16 | 13.81 | -45.69 | 0.226 | -- | 256.62 | -- | 81.56 | -- | -21.34 | -- |
| TAIKO PHARMACEUTICAL CO LTD | 6.40bn | 923.00m | 15.60bn | 214.00 | 16.76 | 1.82 | 13.12 | 2.44 | 18.37 | 18.37 | 127.34 | 169.51 | 0.5080 | 1.77 | 2.62 | -- | 7.34 | -18.99 | 9.32 | -24.04 | 54.42 | 40.20 | 14.44 | -46.31 | 2.72 | -- | 0.0874 | -- | 1.67 | -- | 2.78 | -- | -- | -- |
| ReproCell Inc | 2.52bn | -324.61m | 16.87bn | 99.00 | -- | 1.92 | -- | 6.70 | -3.42 | -3.42 | 26.63 | 92.82 | 0.2328 | 4.15 | 5.92 | 25,450,770.00 | -3.00 | -4.09 | -3.63 | -4.47 | 49.35 | 43.75 | -12.88 | -13.66 | 4.93 | -- | 0.00 | -- | 22.74 | 19.94 | 428.65 | -- | -6.31 | -- |
| Immuno-Biological Laboratories Co., Ltd. | 1.03bn | 363.89m | 16.90bn | 58.00 | 46.43 | 9.59 | 44.20 | 16.38 | 39.07 | 39.07 | 110.76 | 189.25 | 0.5456 | 0.8603 | 4.81 | 17,786,030.00 | 19.25 | -4.96 | 22.46 | -5.77 | 70.35 | 62.70 | 35.27 | -11.27 | 3.96 | 2,702.08 | 0.0947 | -- | 18.71 | 10.95 | 33.40 | -- | -- | -- |
| CanBas Co Ltd (Parent) | 0.00 | -1.25bn | 17.58bn | 14.00 | -- | 7.39 | -- | -- | -64.11 | -64.11 | 0.00 | 120.62 | 0.00 | -- | -- | 0.00 | -44.48 | -57.04 | -46.19 | -62.13 | -- | -- | -- | -4,587.85 | -- | -566.18 | 0.00 | -- | -- | -- | 4.27 | -- | -- | -- |
| Ohki Healthcare Holdings Co Ltd | 359.41bn | 2.43bn | 18.88bn | 648.00 | 7.52 | 0.5509 | 6.67 | 0.0525 | 178.43 | 178.43 | 26,346.69 | 2,435.83 | 2.26 | 9.83 | 4.34 | 554,637,400.00 | 1.53 | 1.77 | 6.23 | 7.74 | 5.31 | 5.26 | 0.677 | 0.6977 | 0.8306 | -- | 0.2686 | 14.17 | 4.42 | 4.74 | 19.41 | 2.21 | 45.68 | 6.47 |
| StemRIM Inc | 0.00 | -1.90bn | 19.18bn | 45.00 | -- | 2.79 | -- | -- | -30.56 | -30.56 | 0.00 | 109.73 | 0.00 | -- | -- | 0.00 | -24.08 | -12.71 | -24.55 | -12.88 | -- | -- | -- | -167.35 | 47.00 | -- | 0.00 | -- | -- | -- | 4.59 | -- | -22.11 | -- |
| Astena Holdings Co Ltd | 62.74bn | 2.19bn | 20.71bn | 1.42k | 9.29 | 0.7507 | 4.50 | 0.3301 | 54.22 | 54.22 | 1,555.72 | 671.41 | 0.8961 | 3.62 | 2.88 | -- | 3.11 | 0.9587 | 6.26 | 1.76 | 34.85 | 30.40 | 3.47 | 1.05 | 0.9228 | -- | 0.4519 | 114.25 | 8.19 | -0.808 | 186.60 | 1.97 | 12.61 | 2.38 |
| Fuso Pharmaceutical Industries Ltd | 62.17bn | -4.01bn | 22.87bn | 1.34k | -- | 0.5962 | -- | 0.3679 | -469.00 | -469.00 | 7,280.21 | 4,059.08 | 0.7307 | 3.25 | 2.32 | 46,394,780.00 | -4.71 | 0.7682 | -9.76 | 1.29 | 26.39 | 26.94 | -6.44 | 1.05 | 0.8228 | 69.88 | 0.4617 | 106.29 | 9.31 | 5.25 | -338.78 | -- | 4.37 | 6.45 |
| Kubota Pharmaceutical Holdings Co Ltd | 21.34m | -676.25m | 23.66bn | 19.00 | -- | 13.04 | -- | 1,108.88 | -10.91 | -10.91 | 0.3341 | 15.72 | 0.0121 | 3.54 | 7.98 | -- | -38.41 | -44.81 | -42.10 | -49.35 | -14.68 | -- | -3,169.69 | -8,411.59 | 12.49 | -- | 0.0121 | -- | -21.53 | -10.80 | 49.26 | -- | -4.55 | -- |
| Renascience Inc | 106.94m | -258.99m | 24.51bn | 3.00 | -- | 9.94 | -- | 229.21 | -20.35 | -20.35 | 8.40 | 186.09 | 0.0479 | -- | 4.86 | 35,648,000.00 | -11.59 | -8.97 | -12.40 | -9.35 | 95.94 | 84.44 | -242.17 | -107.53 | -- | -- | 0.00 | -- | -31.66 | 13.00 | 143.91 | -- | -- | -- |
| RaQualia Pharma Inc | 3.98bn | 273.12m | 26.30bn | 85.00 | 112.75 | 3.59 | 34.55 | 6.61 | 8.97 | 8.97 | 165.54 | 281.96 | 0.3947 | 4.35 | 3.04 | -- | 2.71 | 2.64 | 3.08 | 2.90 | 82.11 | 85.46 | 6.86 | 6.36 | 4.33 | 6.63 | 0.2962 | 0.00 | 28.07 | 29.16 | 155.17 | -- | -13.74 | -- |
Data as of Feb 20 2026. Currency figures normalised to Astena Holdings Co Ltd's reporting currency: Japanese Yen JPY
10.27%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nomura Asset Management Co., Ltd.as of 05 Feb 2026 | 1.24m | 3.02% |
| Dimensional Fund Advisors LPas of 05 Feb 2026 | 1.21m | 2.94% |
| Amova Asset Management Co., Ltd.as of 06 Feb 2026 | 579.10k | 1.41% |
| Daiwa Asset Management Co. Ltd.as of 30 Jan 2026 | 553.50k | 1.35% |
| Mitsubishi UFJ Asset Management Co., Ltd.as of 13 Oct 2025 | 257.50k | 0.63% |
| Nomura Asset Management Taiwan Ltdas of 06 Feb 2026 | 113.00k | 0.28% |
| BlackRock Japan Co. Ltd.as of 05 Feb 2026 | 77.40k | 0.19% |
| Investitori SGR SpAas of 30 Dec 2025 | 68.00k | 0.17% |
| Asset Management One Co., Ltd.as of 05 Feb 2026 | 62.70k | 0.15% |
| Dimensional Fund Advisors Ltd.as of 30 Nov 2025 | 60.63k | 0.15% |
More ▼
Data from 31 Dec 2025 - 11 Feb 2026Source: FactSet Research Systems Inc.
